Advertisement

Topics

Latest "Biomarker discovery Driving technologies" News Stories

17:48 EDT 29th August 2016 | BioPortfolio

Here are the most relevant search results for "Biomarker discovery Driving technologies" found in our extensive news archives from over 250 global news sources.

More Information about Biomarker discovery Driving technologies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Biomarker discovery Driving technologies for you to read. Along with our medical data and news we also list Biomarker discovery Driving technologies Clinical Trials, which are updated daily. BioPortfolio also has a large database of Biomarker discovery Driving technologies Companies for you to search.

Showing "Biomarker discovery Driving technologies" News Articles 1–25 of 11,000+

Extremely Relevant

#news #biotech A new method simplifies blood biomarker discovery and analysis

// Scientists at Karolinska Institutet in collaboration with Estonian Competence Centre on Health Technologies have developed a new gene expression analysis method to widen the usage of blood in biomarker discovery and analysis. Their paper is published in the journal … Continue reading → Cet article #news #biotech A new method simplifies blood biomarker discovery and analysis est appa...


A new method simplifies blood biomarker discovery and analysis

Scientists at Karolinska Institutet in collaboration with Estonian Competence Centre on Health Technologies have developed a new gene expression analysis method to widen the usage of blood in biomarker discovery and analysis. Their paper is published in the journal Scientific Reports.

Scientists develop novel method to widen usage of blood in biomarker discovery and analysis

Scientists at Karolinska Institutet in collaboration with Estonian Competence Centre on Health Technologies have developed a new gene expression analysis method to widen the usage of blood in biomarker discovery and analysis. Their paper is published in the journal Scientific Reports.


Relevant

University of Manchester and SCIEX open £18m Biomarker Discovery Centre

The Manchester, UK-based Stoller Biomarker Discovery Centre is a major step forward in precision medicine and making 'industrial' proteomics a reality

New method simplifies blood biomarker discovery and analysis

A new gene expression analysis method has been developed to widen the usage of blood in biomarker discovery and analysis, report scientists in a new article.

Biomarker Discovery Offers New Hope for TB Vaccine

A team of scientists led by Oxford University have made a discovery that could improve our chances of developing an effective vaccine against Tuberculosis. The researchers have identified new biomarkers for Tuberculosis (TB) which have shown for the first time why immunity from the widely used Bacillus Calmette-Guérin (BCG) vaccine is so variable. The biomarkers will also provide valuable clues ...

Biomarker drug discovery company Blueprint Bio receives $7.5mm in Series A round

Blueprint Bio Inc. (personalized medicine using biomarker drug discovery) secured $7.5mm in its Series A financing round from Forentis Partners LLC. The company will use the proceeds to further develop its intellectual property and support additional drug discoveries.

Stemina Biomarker Discovery Announces Rebranding of Its Diagnostics Business, New Board Member Kevin Krenitsky, MD, and Progress from Its Clinical Study

Tuesday, May 10th 2016 at 1:32pm UTC MADISON, Wis.–(BUSINESS WIRE)– Stemina Biomarker Discovery Inc. today announced it has rebranded its diagnostics business to more accurately represent its focus on neurological disorders. NeuroPointDX is transforming diagnosis and allowing more precise treatment of neurological disorders based on the patient’s metabolism. The company’s proprieta...

Biomarker drug discovery company Blueprint Bio receives $7.5mm in early-stage funding

Blueprint Bio Inc. (personalized medicine using biomarker drug discovery) secured $7.5mm in early-stage funding from Forentis Partners LLC. The company will use the proceeds to further develop its intellectual property and support additional drug discoveries.

Biomarker discovery offers hope for new TB vaccine

A team of scientists led by Oxford University have made a discovery that could improve our chances of developing an effective vaccine against Tuberculosis.

C4X Discovery acquires more drug discovery technology from insolvent MolPlex

British company C4X Discovery has acquired a suite of advanced drug-discovery technologies from MolPlex…

Definiens Launches Clinical Development Offering to Provide Services from Discovery to ...

New Service Provides Comprehensive Solution for Tissue-Based Assay Development, Image Analysis and Biomarker Signature Discovery Read more...

Uber buys self-driving truck startup Otto; teams up with Volvo

Aug 18 (Reuters) - Ride service Uber Technologies Inc said on Thursday it has acquired the self-driving trucks startup Otto, and it also announced that Volvo Car Group has agreed to a $300 million alliance to develop self-driving cars.

UPDATE 1-Uber buys self-driving truck startup Otto; teams with Volvo

Aug 18 (Reuters) - Ride service Uber Technologies Inc said on Thursday it acquired self-driving trucks startup Otto and formed a $300 million alliance with Volvo Car Group to develop self-driving cars.

CORRECTED-UPDATE 1-Uber buys self-driving truck startup Otto; teams with Volvo

Aug 18 (Reuters) - Ride service Uber Technologies Inc said on Thursday it acquired self-driving trucks startup Otto and formed a $300 million alliance with Volvo Car Group to develop self-driving cars.

Oxford Global’s 3rd Annual Drug Discovery USA Congress – Final Agenda

Have you seen the final agenda for our 3rd Annual Drug Discovery USA Congress? Our expert panel of speakers will address the current strategies for directed discovery, including the resurgence of phenotypic screening and comparing its utility with target based discovery. They will explore novel peptide drug discovery, strategies for target selection and incorporating genomic technologies into dis...

Aelan licenses Buck Institute's AD biomarker IP

Aelan Cell Technologies licensed worldwide development and commercialization rights to Buck Institute for Research on Aging's intellectual property related to an epigenetic biomarker associated with human aging for potential use in Alzheimer's disease detection.

Ten New Grants Support Alzheimer's Drug Discovery & Biomarker Development

Metabolomics in rheumatic diseases: desperately seeking biomarkers

In the setting of inflammatory diseases, metabolic profiling has potential applications in diagnosis, monitoring and defining disease pathogenesis. This Review focuses on metabolomic studies in rheumatic diseases, including discussion of state-of-the-art technologies, recent insights into disease mechanisms and treatment targets, and the feasibility of metabolomics for biomarker discovery.

Parkinson's Disease Biomarker Found in Urinary Samples

A biomarker helps physicians predict, diagnose or monitor disease, because the biomarker corresponds to the presence or risk of disease,...

Technology, not capacity, driving Catalent’s biologics strategy

Differentiated technologies buoyed by the recent $600m conjugation deal with Roche is driving Catalent’s biologics business, the firm told Biopharma-Reporter at BIO.

BluePen Biomarkers announces collaboration with the University of Pennsylvania

(University of Pennsylvania) The University of Pennsylvania has co-founded and structured BluePen Biomarkers in collaboration with BluePrint Bio, Inc. and Emerald Logic, Inc. to conduct biomarker research and identification. BluePen is creating a comprehensive biomarker measurement and discovery pipeline for the acceleration of personalized medicine.

Richard Buller, VP at Pfizer, to Give a Keynote at GTCbio’s Biomarker Summit Europe 2016

Berlin, Germany, July 10, 2016 --(PR.com)-- Richard E. Buller, Vice President of Oncology, Clinical Development & Head of Global Product Development at Pfizer will give a keynote presentation on, "Feedback Loops Between Biomarkers and Targeted Agents in Clinical Trials and Beyond: Lessons from Anaplastic Lymphoma Kinase (ALK+) Driven Non-Small Cell Lung Cancer (NSCLC)" at GTCbioR...

Glycomics and Glycoproteomics by CESI-MS for Biomarker Discovery and Biopharmaceutical Characterization

Glycosylation is one of the most prevalent co- and post-translational modifications of human proteins and is known to affect the protein properties. Glycosylation is known to be involved in many different diseases. The sialic acids at the end of the glycan chain serve as a binding site for toxins, pathogens and human lectins in a linkage-specific manner having great biomarker potential. During th...

T2 Biosystems Announces Research and Development Collaboration with Bayer to Advance Drug Monitoring and Biomarker Discovery for Blood Coagulation Disorders

LEXINGTON, Mass., July 18, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, has signed a multi-year agreement to provide T2 Biosystems’ T2 Magnetic Resonance technology platform, or T2MR®, for Bayer’s research and development efforts in blood coagulation disorders. This collaboration will develop to...


Quick Search
Advertisement
 

News Quicklinks